ASM Microbe 2026
June 4-7, 2026 – Washington, DC, USA
ADLM 2026
July 26-30, 2026 – Anaheim, CA, USA

What is the Major Side Effect of Methotrexate?

Methotrexate is a medication used by doctors to treat a variety of diseases. The medical community has confirmed the efficacy of methotrexate, but healthcare professionals and patients need to understand the potential side effects of using this potent drug in order to achieve the best treatment results. Among the many possible side effects, the main side effect of methotrexate is hepatotoxicity, which is a toxic effect on the liver. If not properly monitored, the severity can range from mild elevation of liver enzymes to severe liver damage.

Understanding Methotrexate and Its Mechanism

Methotrexate belongs to a class of drugs called antimetabolites. The drug functions through its ability to stop dihydrofolate reductase (DHFR) from working which prevents cells from creating DNA and multiplying. Methotrexate functions by stopping the growth of fast-replicating cells through its mechanism which prevents cell division from occurring. Methotrexate's therapeutic effect stems from this mechanism of action, but the same mechanism can also lead to organ toxicity during drug metabolism, especially in the liver.

The cellular pharmacology of MTX. Figure 1. MTX cellular pharmacology and mechanism of action. (Source: Vermeer E, et al.; 2023)

The three factors which determine side effect occurrence and intensity include drug dosage and administration schedule and delivery method. Low-dose methotrexate is commonly prescribed for autoimmune conditions and is generally well-tolerated. The cancer treatment drug high-dose methotrexate requires patients to receive close medical surveillance because it produces severe side effects which can be managed through folinic acid rescue treatment.

Hepatotoxicity: The Primary Concern

Methotrexate causes liver toxicity which represents the most dangerous side effect that affects patients in clinical practice. The liver becomes damaged through hepatotoxicity which results in three main patterns of liver damage that include elevated liver enzyme levels of ALT and AST and two additional patterns of fatty liver disease and fibrosis and cirrhosis. The risk of liver damage becomes higher when patients receive multiple doses of methotrexate and when their treatment duration becomes longer and when they have conditions like alcohol use and obesity and diabetes and pre-existing liver problems.

People who receive methotrexate treatment for extended periods need to get their liver function tested through LFTs on a regular basis. Physicians can prevent permanent liver damage through early detection of liver enzyme elevations which enables them to modify medication amounts and stop treatment temporarily and start protective strategies.

Other Notable Side Effects

While hepatotoxicity is the major side effect, methotrexate can also cause a range of other adverse effects that patients should be aware of:

  • Bone Marrow Suppression: The drug Methotrexate causes white blood cells and red blood cells and platelets to decrease in number which results in higher infection risk and anemia and bleeding problems.
  • The main gastrointestinal symptoms which occur at higher doses include nausea and vomiting and diarrhea and mouth ulcers. The side effects of this medication depend on the dosage amount and doctors can help patients control these effects through folic acid supplements.
  • The use of methotrexate leads to pulmonary toxicity which results in pneumonitis that causes lung damage and produces symptoms including cough and shortness of breath and fever in patients. Doctors can prevent dangerous respiratory problems from developing when they identify symptoms at their beginning stage.
  • The treatment causes skin-related side effects which include rash development and skin sensitivity to sunlight and hair loss. Stevens-Johnson syndrome exists as a rare medical condition which produces dangerous skin reactions.
  • The high doses of methotrexate treatment lead to kidney damage which becomes more severe when patients have existing kidney problems or when they experience dehydration. The medical team needs to monitor patient kidney function at the same time as they manage their fluid requirements.

Factors That Increase Risk of Side Effects

Multiple elements exist which increase the chances of developing side effects from methotrexate treatment. These include:

  • The medication causes increased risk of liver damage and bone marrow cell destruction when patients take it for more than a few months.
  • Older adults experience decreased liver and kidney function as they age which makes them more susceptible to toxic substance side effects.
  • Patients who consume any amount of alcohol will develop liver damage which worsens when they receive methotrexate treatment.
  • The drug interactions between methotrexate and nonsteroidal anti-inflammatory drugs (NSAIDs) and antibiotics and hepatotoxic drugs result in elevated toxic effects of methotrexate.
  • Patients who already have liver or kidney or lung conditions will develop more serious side effects.

Preventing and Managing Side Effects

Healthcare providers use different methods to reduce dangerous side effects which methotrexate causes in patients.

  • The standard medical practice includes routine blood tests which monitor liver function and kidney function and complete blood counts.
  • The medical team provides folic acid or folinic acid supplements to patients who need them because these medications help prevent mouth sores and gastrointestinal problems and bone marrow suppression.
  • The treatment plan needs dose adjustments which depend on patient age and kidney function and treatment response to reach the best results while minimizing potential side effects.
  • The treatment plan includes advice for patients to reduce their alcohol consumption while keeping their weight normal and staying away from substances which harm the liver.
  • The patient needs to learn about the first indicators which include jaundice and persistent cough and unusual bruising and shortness of breath to receive proper treatment at the right time.

Conclusion

Methotrexate functions as a primary therapeutic agent which treats different cancers and autoimmune disorders because it successfully manages fast cell proliferation and immune system control. The main side effect of hepatotoxicity requires healthcare providers to closely monitor patients while taking steps for prevention. The treatment of other essential side effects which include bone marrow suppression and gastrointestinal problems and pulmonary complications and skin reactions needs specific approaches together with patient education and regular laboratory tests to minimize risks.

Patients who receive methotrexate treatment need to stay in touch with their doctor while they should immediately share any strange body reactions and follow all scheduled medical check-ups. Methotrexate treatment for extended disease control becomes possible through its safe administration which combines therapeutic advantages with proper management of potential adverse effects.

FAQs

Antibody FAQs

Still have questions?

Contact Us

The most dangerous side effect of this medication occurs when it damages liver tissue which leads to elevated liver enzymes and potentially cirrhosis when proper surveillance is absent.

The medication causes side effects which affect bone marrow and lungs and kidneys and skin although these occurrences happen less frequently than liver damage.

The management of side effects requires patients to undergo scheduled blood tests and receive folic acid supplements and doctors should make treatment adjustments and patients need to follow specific lifestyle rules which include reducing their alcohol consumption.

Reference

  1. Vermeer E, et al.; Oral Versus Subcutaneous Methotrexate in Immune-Mediated Inflammatory Disorders: an Update of the Current Literature. Curr Rheumatol Rep. 2023, 25(12):276-284.

Methotrexate Antibodies

Methotrexate Antigen

TargetCat. No.Product NameConjugateApplication
MTXDAGB319Methotrexate [HRP]HRPIAInquiry
DAGA-351BMethotrexate [BSA]BSALFIAInquiry
DAGA-351KMethotrexate [KLH]KLHImmunogenInquiry
DWT109Methotrexate Standard solutionN/AInquiry
DAG-WZ3635OMethotrexate [OVA]OVAIAInquiry

Methotrexate ELISA

TargetCat. No.Product NameSizeSpecies ReactivityApplicationDetection Sample
MTXDEIA-US209Methotrexate ELISA kit96THuman, mouse, ratQuantitativeSerum, plasma and urineInquiry
DEIA-XYZ209Methotrexate ELISA kit96THumanQuantitativeSerum, PlasmaInquiry
Inquiry Basket